POYHONEN JOHN
SEC CIK 1286100 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | Pres, CCO | 46.6K | — | — | 18 | 2021-04-30 | 2023-04-13 |
Most active insiders at HRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cusack Thomas | Dir | — | — |
| 2 | Hensley Mark Earl | COO | — | — |
| 3 | Morgan Adam | Dir | — | — |
| 4 | Rosen David Efraim | 10% | — | — |
| 5 | Dissanaike Sharmila | Dir | — | — |
| 6 | Kaseta Michael | Dir | — | — |
| 7 | Christian Waage | Dir | — | — |
| 8 | Duarte Ira | EVP, CFO | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Collard Craig A | CEO, Dir | — | — |
POYHONEN JOHN made no open-market trades at HRTX in the last 12 months.
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-17 | 2023-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | F - Tax | $2.88 | -2,012 | 46.6K | -4% | -$5,795 |
| DM | 2023-04-17 | 2023-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | M - OptEx | — | +5,814 | 48.7K | +14% | — |
| DM | 2023-01-17 | 2023-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | M - OptEx | — | +5,814 | 44.9K | +15% | — |
| D | 2023-01-17 | 2023-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | F - Tax | $3.17 | -2,012 | 42.8K | -4% | -$6,378 |
| DM | 2022-10-17 | 2022-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | M - OptEx | — | +5,814 | 41.1K | +16% | — |
| D | 2022-10-17 | 2022-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | F - Tax | $3.76 | -2,012 | 39.0K | -5% | -$7,565 |
| D | 2022-07-15 | 2022-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | F - Tax | $3.01 | -2,012 | 35.2K | -5% | -$6,056 |
| DM | 2022-07-15 | 2022-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | M - OptEx | — | +5,814 | 37.3K | +18% | — |
| DM | 2022-04-15 | 2022-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | M - OptEx | — | +5,814 | 28.9K | +25% | — |
| D | 2022-04-15 | 2022-04-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | F - Tax | $6.07 | -2,012 | 31.4K | -6% | -$12.2K |
| DM | 2022-01-14 | 2022-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | M - OptEx | — | +5,814 | 25.1K | +30% | — |
| D | 2022-01-14 | 2022-01-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | F - Tax | $8.30 | -2,012 | 27.6K | -7% | -$16.7K |
| 2021-12-23 | 2021-10-29 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | J - Other | $9.36 | +817 | 23.8K | +4% | +$7,647 | |
| D | 2021-10-15 | 2021-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | F - Tax | $10.55 | -433 | 23.0K | -2% | -$4,568 |
| D | 2021-10-15 | 2021-10-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | M - OptEx | — | +1,250 | 23.5K | +6% | — |
| D | 2021-07-15 | 2021-04-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | J - Other | $13.90 | +971 | 21.4K | +5% | +$13.5K |
| D | 2021-07-15 | 2021-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | M - OptEx | — | +1,250 | 22.6K | +6% | — |
| D | 2021-07-15 | 2021-07-13 | HRTX | HERON THERAPEUTICS, INC. /DE/ | POYHONEN JOHN | Pres, CCO | F - Tax | $13.48 | -433 | 22.2K | -2% | -$5,837 |
Purchase Sale Sale after option exercise All abbreviations